BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 23 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $214,892 | -17.2% | 5,694 | 0.0% | 0.04% | -13.7% |
Q2 2023 | $259,419 | +12.3% | 5,694 | 0.0% | 0.05% | +8.5% |
Q1 2023 | $230,949 | +79537.6% | 5,694 | 0.0% | 0.05% | -24.2% |
Q4 2022 | $290 | -99.9% | 5,694 | 0.0% | 0.06% | -10.1% |
Q3 2022 | $307,000 | -16.1% | 5,694 | 0.0% | 0.07% | -11.5% |
Q2 2022 | $366,000 | -17.2% | 5,694 | 0.0% | 0.08% | -9.3% |
Q1 2022 | $442,000 | -9.6% | 5,694 | 0.0% | 0.09% | -10.4% |
Q4 2021 | $489,000 | +6.8% | 5,694 | 0.0% | 0.10% | -5.0% |
Q3 2021 | $458,000 | 0.0% | 5,694 | 0.0% | 0.10% | -7.3% |
Q2 2021 | $458,000 | -4.6% | 5,694 | 0.0% | 0.11% | -11.4% |
Q1 2021 | $480,000 | +5.0% | 5,694 | 0.0% | 0.12% | +3.4% |
Q4 2020 | $457,000 | -0.2% | 5,694 | 0.0% | 0.12% | -19.6% |
Q3 2020 | $458,000 | -6.5% | 5,694 | 0.0% | 0.15% | -11.9% |
Q2 2020 | $490,000 | +6.1% | 5,694 | 0.0% | 0.17% | +11.3% |
Q1 2020 | $462,000 | -2.9% | 5,694 | 0.0% | 0.15% | +20.8% |
Q4 2019 | $476,000 | -4.4% | 5,694 | 0.0% | 0.12% | -9.4% |
Q3 2019 | $498,000 | +5.7% | 5,694 | 0.0% | 0.14% | +11.3% |
Q2 2019 | $471,000 | +1.7% | 5,694 | 0.0% | 0.12% | -3.1% |
Q1 2019 | $463,000 | +23.5% | 5,694 | 0.0% | 0.13% | +11.3% |
Q4 2018 | $375,000 | -14.6% | 5,694 | 0.0% | 0.12% | -0.9% |
Q3 2018 | $439,000 | +4.5% | 5,694 | 0.0% | 0.12% | 0.0% |
Q2 2018 | $420,000 | +13.5% | 5,694 | 0.0% | 0.12% | +3.6% |
Q1 2018 | $370,000 | +0.5% | 5,694 | 0.0% | 0.11% | +1.8% |
Q4 2017 | $368,000 | -84.7% | 5,694 | -63.6% | 0.11% | -86.5% |
Q3 2017 | $2,410,000 | +598.6% | 15,640 | +174.7% | 0.82% | +604.3% |
Q2 2017 | $345,000 | +16.9% | 5,694 | 0.0% | 0.12% | +13.7% |
Q1 2017 | $295,000 | +17.1% | 5,694 | 0.0% | 0.10% | +5.2% |
Q4 2016 | $252,000 | +7.7% | 5,694 | 0.0% | 0.10% | -14.2% |
Q1 2016 | $234,000 | +2.2% | 5,694 | -5.0% | 0.11% | +2.7% |
Q4 2015 | $229,000 | +22.5% | 5,994 | +5.3% | 0.11% | +18.3% |
Q3 2015 | $187,000 | -76.5% | 5,694 | -50.0% | 0.09% | -76.6% |
Q2 2015 | $796,000 | +104.1% | 11,388 | +100.0% | 0.40% | +109.5% |
Q1 2015 | $390,000 | -6.7% | 5,694 | 0.0% | 0.19% | -13.2% |
Q4 2014 | $418,000 | +2.0% | 5,694 | -0.4% | 0.22% | -4.4% |
Q3 2014 | $410,000 | – | 5,714 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
Third Point | 4,000,000 | $344,400,000 | 4.72% |
Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |